共 39 条
[1]
Korth-Bradley JM(2018)The path to perfect pediatric posology - drug development in pediatrics J Clin Pharmacol 58 S48-S57
[2]
O'Hara K(2015)Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future Br J Clin Pharmacol 80 1281-1288
[3]
Wright IM(2016)Antimicrobial agent dosing in infants Clin Ther 38 1948-1960
[4]
Schneider JJ(2011)Innovative clinical trial design for pediatric therapeutics Expert Rev Clin Pharmacol 4 643-652
[5]
Jones AL(2007)Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone Pediatrics 119 716-721
[6]
Martin JH(2017)Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: findings from the Clinical Trials Transformation Initiative Contemp Clin Trials Commun 9 7-12
[7]
Johnson JK(2016)Discontinuation and nonpublication of randomized clinical trials conducted in children Pediatrics 138 382-388
[8]
Laughon MM(2004)Why ethnic minority groups are under-represented in clinical trials: a review of the literature Health Soc Care Community 12 1091-1096
[9]
Laughon MM(2014)Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials Cancer 120 505-513
[10]
Benjamin DK(2021)Racial and ethnic diversity in studies funded under the Best Pharmaceuticals for Children Act Pediatrics 147 71-79